|
12 Jan 2007 |
Ecopia’s Phase I Dose-Escalation Portion Successfully Completed
|
|
12 Jan 2007 |
Organon to submit antidepressant mirtazapine for approval in Japan significantly earlier than expected
|
|
12 Jan 2007 |
PBI-1402 Enters Clinical Trial For Anemia Associated With Chronic Kidney Disease
|
|
12 Jan 2007 |
Chelsea Therapeutics Announces Results of European Phase IIb Trial of Droxidopa
|
|
11 Jan 2007 |
The right balance drives the field of PPAR agonist R&D
|
|
11 Jan 2007 |
Basilea Announces Positive Top-line Results on Second Pivotal Phase III Ceftobiprole Trial
|
|
11 Jan 2007 |
InteKrin Therapeutics Licenses Diabetes Product
|
|
11 Jan 2007 |
New England Journal of Medicine Reports Aegerion's Lead Compound Reduces LDL By 51% in Patients With a Severe Form of Hypercholesterolemia
|
|
11 Jan 2007 |
Icagen Provides Update on Pain Program Including Its SCN9A Sodium Channel Program
|
|
10 Jan 2007 |
Xytis Begins Phase II Clinical Study With Anatibant (XY2405) For Traumatic Brain Injury
|
|
10 Jan 2007 |
Biogen Idec Initiates Phase III Clinical Program Of Oral Compound BG-12 For Multiple Sclerosis
|
|
10 Jan 2007 |
ZIOPHARM Initiates ZIO-101 Phase II Study in Hematological Cancers
|
|
10 Jan 2007 |
Anthera Receives IND Approval from FDA to begin phase 2 “IMPACTS†trial with A-001 for prevention of acute chest syndrome in patients with sickle cell disease
|
|
09 Jan 2007 |
Protherics submits DigiFab(TM) New Drug Submission in Canada
|
|
09 Jan 2007 |
XenoPort Announces Advancements in Clinical Development Programs
|
|
09 Jan 2007 |
Xytis merges and raises $24.5M
|
|
09 Jan 2007 |
Neurocrine Biosciences Announces Positive Results From Second Phase II Study With Its Orally Active GnRH Receptor Antagonist in Endometriosis
|
|
09 Jan 2007 |
AEterna Zentaris Initiates Phase 1 Trial for ZEN-012, a new small molecule oral anti-cancer drug - IND accepted by FDA
|
|
09 Jan 2007 |
Myriad Genetics Announces Results of Phase 2 Prostate Cancer Trial
|
|
09 Jan 2007 |
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
|
|
09 Jan 2007 |
Incyte to Report Positive Preliminary Clinical Results from HIV and Diabetes Programs and Highlight Progress in Several Drug Development Programs at the 25th JPMorgan Healthcare Conference
|
|
09 Jan 2007 |
The Medicines Company's Cleviprex(TM) (Clevidipine) Phase III Safety Trials Meet Pre-Specified Objectives
|
|
09 Jan 2007 |
Anesiva Announces Clinical Plan for Pivotal Testing of 4975, Long-Acting Pain Candidate
|
|
09 Jan 2007 |
deCODE Advancing Lead Product Development Programs
|
|
09 Jan 2007 |
Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 Trial of Its Novel Antifolate PDX in Patients With Peripheral T-cell Lymphoma
|
